Patent · US Active

Therapeutic use of interferon-polymer conjugates

US8617532B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

PHARMAESSENTIA CORPORATION · TW

Inventors

Ko-Chung Lin · Lexington, US
Rudolf Widmann · Purkersdorf, AT

Key dates

Filing date	Dec 9, 2010
Grant date	Dec 31, 2013
Priority date	—
Expiry date	Sep 14, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/56
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to use protein-polymer conjugates described in the specification to treat various diseases, including disease is idiopaic myelofibrsis, polycythaemia vera, and essential thromobocythaemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.